148 related articles for article (PubMed ID: 32528278)
1. Obg-Like ATPase 1 Enhances Chemoresistance of Breast Cancer
Liu J; Miao X; Xiao B; Huang J; Tao X; Zhang J; Zhao H; Pan Y; Wang H; Gao G; Xiao GG
Front Pharmacol; 2020; 11():666. PubMed ID: 32528278
[TBL] [Abstract][Full Text] [Related]
2. Obg-like ATPase 1 inhibited oral carcinoma cell metastasis through TGFβ/SMAD2 axis in vitro.
Liu J; Yang Q; Xiao KC; Dobleman T; Hu S; Xiao GG
BMC Mol Cell Biol; 2020 Sep; 21(1):65. PubMed ID: 32928102
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of Obg-like ATPase 1 enhances sorafenib sensitivity by inhibition of GSK-3β/β-catenin signaling in hepatocellular carcinoma cells.
Bian R; Zhao J; Yao Z; Cai Y; Shou C; Lou D; Zhou L; Qian Y
J Gastrointest Oncol; 2022 Jun; 13(3):1255-1265. PubMed ID: 35837205
[TBL] [Abstract][Full Text] [Related]
4. OLA1 contributes to epithelial-mesenchymal transition in lung cancer by modulating the GSK3β/snail/E-cadherin signaling.
Bai L; Yu Z; Zhang J; Yuan S; Liao C; Jeyabal PV; Rubio V; Chen H; Li Y; Shi ZZ
Oncotarget; 2016 Mar; 7(9):10402-13. PubMed ID: 26863455
[TBL] [Abstract][Full Text] [Related]
5. OLA1 is a potential prognostic molecular biomarker for endometrial cancer and promotes tumor progression.
Dong Y; Yin A; Xu C; Jiang H; Wang Q; Wu W; Guo S
Oncol Lett; 2021 Aug; 22(2):576. PubMed ID: 34122627
[TBL] [Abstract][Full Text] [Related]
6. OLA1, an Obg-like ATPase, suppresses antioxidant response via nontranscriptional mechanisms.
Zhang J; Rubio V; Lieberman MW; Shi ZZ
Proc Natl Acad Sci U S A; 2009 Sep; 106(36):15356-61. PubMed ID: 19706404
[TBL] [Abstract][Full Text] [Related]
7. The BRCA1/BARD1-interacting protein OLA1 functions in centrosome regulation.
Matsuzawa A; Kanno S; Nakayama M; Mochiduki H; Wei L; Shimaoka T; Furukawa Y; Kato K; Shibata S; Yasui A; Ishioka C; Chiba N
Mol Cell; 2014 Jan; 53(1):101-14. PubMed ID: 24289923
[TBL] [Abstract][Full Text] [Related]
8. OLA1 promotes colorectal cancer tumorigenesis by activation of HIF1α/CA9 axis.
Liu Y; Kong XX; He JJ; Xu YB; Zhang JK; Zou LY; Ding KF; Xu D
BMC Cancer; 2022 Apr; 22(1):424. PubMed ID: 35440019
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance of Obg-like ATPase 1 and its association with Snail in gastric cancer.
Wang J; Cao Q; Wang Z
Pol J Pathol; 2023; 74(1):42-50. PubMed ID: 37306352
[TBL] [Abstract][Full Text] [Related]
10. Obg-like ATPase 1 regulates global protein serine/threonine phosphorylation in cancer cells by suppressing the GSK3β-inhibitor 2-PP1 positive feedback loop.
Xu D; Song R; Wang G; Jeyabal PV; Weiskoff AM; Ding K; Shi ZZ
Oncotarget; 2016 Jan; 7(3):3427-39. PubMed ID: 26655089
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
Ling YH; Jiang JD; Holland JF; Perez-Soler R
Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
[TBL] [Abstract][Full Text] [Related]
12. BRCA1-Interacting Protein OLA1 Requires Interaction with BARD1 to Regulate Centrosome Number.
Yoshino Y; Qi H; Fujita H; Shirota M; Abe S; Komiyama Y; Shindo K; Nakayama M; Matsuzawa A; Kobayashi A; Ogoh H; Watanabe T; Ishioka C; Chiba N
Mol Cancer Res; 2018 Oct; 16(10):1499-1511. PubMed ID: 29858377
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
[TBL] [Abstract][Full Text] [Related]
14. Metal mixture (As-Cd-Pb)-induced cell transformation is modulated by OLA1.
Martínez-Baeza E; Rojas E; Valverde M
Mutagenesis; 2016 Jul; 31(4):463-73. PubMed ID: 26984302
[TBL] [Abstract][Full Text] [Related]
15. Knockout of Brca1-interacting factor Ola1 in female mice induces tumors with estrogen suppressible centrosome amplification.
Yoshino Y; Ogoh H; Iichi Y; Sasaki T; Yoshida T; Ichimura S; Nakayama M; Xi W; Fujita H; Kikuchi M; Fang Z; Li X; Abe T; Futakuchi M; Nakamura Y; Watanabe T; Chiba N
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167138. PubMed ID: 38537683
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA; Vellon L; Colomer R; Lupu R
Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
[TBL] [Abstract][Full Text] [Related]
17. Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer.
Gao C; Yuan X; Jiang Z; Gan D; Ding L; Sun Y; Zhou J; Xu L; Liu Y; Wang G
Breast Cancer Res Treat; 2019 Jul; 176(2):291-301. PubMed ID: 31006103
[TBL] [Abstract][Full Text] [Related]
18. MHP-1 inhibits cancer metastasis and restores topotecan sensitivity via regulating epithelial-mesenchymal transition and TGF-β signaling in human breast cancer cells.
Lin S; Lyu X; Yu J; Sun L; Du D; Lai Y; Li H; Wang Y; Zhang L; Yin H; Yuan S
Phytomedicine; 2016 Sep; 23(10):1053-63. PubMed ID: 27444351
[TBL] [Abstract][Full Text] [Related]
19. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y
Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464
[TBL] [Abstract][Full Text] [Related]
20. Identification and development of Tetra-ARMS PCR-based screening test for a genetic variant of OLA1 (Tyr254Cys) in the human failing heart.
Dubey PK; Dubey S; Singh S; Bhat PD; Pogwizd S; Krishnamurthy P
medRxiv; 2023 Oct; ():. PubMed ID: 37905026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
